Literature DB >> 19542530

Secreted versus membrane-anchored collagenases: relative roles in fibroblast-dependent collagenolysis and invasion.

Farideh Sabeh1, Xiao-Yan Li, Thomas L Saunders, R Grant Rowe, Stephen J Weiss.   

Abstract

Fibroblasts degrade type I collagen, the major extracellular protein found in mammals, during events ranging from bulk tissue resorption to invasion through the three-dimensional extracellular matrix. Current evidence suggests that type I collagenolysis is mediated by secreted as well as membrane-anchored members of the matrix metalloproteinase (MMP) gene family. However, the roles played by these multiple and possibly redundant, degradative systems during fibroblast-mediated matrix remodeling is undefined. Herein, we use fibroblasts isolated from Mmp13(-/-), Mmp8(-/-), Mmp2(-/-), Mmp9(-/-), Mmp14(-/-) and Mmp16(-/-) mice to define the functional roles for secreted and membrane-anchored collagenases during collagen-resorptive versus collagen-invasive events. In the presence of a functional plasminogen activator-plasminogen axis, secreted collagenases arm cells with a redundant collagenolytic potential that allows fibroblasts harboring single deficiencies for either MMP-13, MMP-8, MMP-2, or MMP-9 to continue to degrade collagen comparably to wild-type fibroblasts. Likewise, Mmp14(-/-) or Mmp16(-/-) fibroblasts retain near-normal collagenolytic activity in the presence of plasminogen via the mobilization of secreted collagenases, but only Mmp14 (MT1-MMP) plays a required role in the collagenolytic processes that support fibroblast invasive activity. Furthermore, by artificially tethering a secreted collagenase to the surface of Mmp14(-/-) fibroblasts, we demonstrate that localized pericellular collagenolytic activity differentiates the collagen-invasive phenotype from bulk collagen degradation. Hence, whereas secreted collagenases arm fibroblasts with potent matrix-resorptive activity, only MT1-MMP confers the focal collagenolytic activity necessary for supporting the tissue-invasive phenotype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19542530      PMCID: PMC2755707          DOI: 10.1074/jbc.M109.002808

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  91 in total

1.  Role of cathepsin K in the turnover of the dermal extracellular matrix during scar formation.

Authors:  Thomas M Rünger; Maria Josefina Quintanilla-Dieck; Jag Bhawan
Journal:  J Invest Dermatol       Date:  2006-08-31       Impact factor: 8.551

2.  A critical role for the membrane-type 1 matrix metalloproteinase in collagen phagocytosis.

Authors:  Hyejin Lee; Christopher M Overall; Christopher A McCulloch; Jaro Sodek
Journal:  Mol Biol Cell       Date:  2006-09-13       Impact factor: 4.138

Review 3.  Structure and function of matrix metalloproteinases and TIMPs.

Authors:  Hideaki Nagase; Robert Visse; Gillian Murphy
Journal:  Cardiovasc Res       Date:  2006-01-05       Impact factor: 10.787

Review 4.  Matrix metalloproteinases and the regulation of tissue remodelling.

Authors:  Andrea Page-McCaw; Andrew J Ewald; Zena Werb
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

5.  Collagen degradation by interleukin-1beta-stimulated gingival fibroblasts is accompanied by release and activation of multiple matrix metalloproteinases and cysteine proteinases.

Authors:  S W Cox; B M Eley; M Kiili; A Asikainen; T Tervahartiala; T Sorsa
Journal:  Oral Dis       Date:  2006-01       Impact factor: 3.511

6.  Characterization of the mechanisms by which gelatinase A, neutrophil collagenase, and membrane-type metalloproteinase MMP-14 recognize collagen I and enzymatically process the two alpha-chains.

Authors:  Magda Gioia; Susanna Monaco; Giovanni Francesco Fasciglione; Anna Coletti; Andrea Modesti; Stefano Marini; Massimo Coletta
Journal:  J Mol Biol       Date:  2007-03-02       Impact factor: 5.469

7.  Activity of matrix metalloproteinase-9 against native collagen types I and III.

Authors:  Heather F Bigg; Andrew D Rowan; Michael D Barker; Tim E Cawston
Journal:  FEBS J       Date:  2007-03       Impact factor: 5.542

8.  RNA interference inhibition of matrix metalloproteinase-1 prevents melanoma metastasis by reducing tumor collagenase activity and angiogenesis.

Authors:  Jessica S Blackburn; C Harker Rhodes; Charles I Coon; Constance E Brinckerhoff
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

9.  Urokinase-type plasminogen activator stimulation of monocyte matrix metalloproteinase-1 production is mediated by plasmin-dependent signaling through annexin A2 and inhibited by inactive plasmin.

Authors:  Yahong Zhang; Zhao-Hua Zhou; Thomas H Bugge; Larry M Wahl
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

10.  Extracellular collagenases and the endocytic receptor, urokinase plasminogen activator receptor-associated protein/Endo180, cooperate in fibroblast-mediated collagen degradation.

Authors:  Daniel H Madsen; Lars H Engelholm; Signe Ingvarsen; Thore Hillig; Rebecca A Wagenaar-Miller; Lars Kjøller; Henrik Gårdsvoll; Gunilla Høyer-Hansen; Kenn Holmbeck; Thomas H Bugge; Niels Behrendt
Journal:  J Biol Chem       Date:  2007-07-09       Impact factor: 5.157

View more
  65 in total

1.  Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth.

Authors:  Albert G Remacle; Vladislav S Golubkov; Sergey A Shiryaev; Russell Dahl; John L Stebbins; Andrei V Chernov; Anton V Cheltsov; Maurizio Pellecchia; Alex Y Strongin
Journal:  Cancer Res       Date:  2012-03-09       Impact factor: 12.701

2.  MT1-MMP regulates the PI3Kδ·Mi-2/NuRD-dependent control of macrophage immune function.

Authors:  Ryoko Shimizu-Hirota; Wanfen Xiong; B Timothy Baxter; Steven L Kunkel; Ivan Maillard; Xiao-Wei Chen; Farideh Sabeh; Rui Liu; Xiao-Yan Li; Stephen J Weiss
Journal:  Genes Dev       Date:  2012-02-15       Impact factor: 11.361

Review 3.  The impact of the extracellular matrix on inflammation.

Authors:  Lydia Sorokin
Journal:  Nat Rev Immunol       Date:  2010-10       Impact factor: 53.106

Review 4.  Forcing form and function: biomechanical regulation of tumor evolution.

Authors:  Hongmei Yu; Janna Kay Mouw; Valerie M Weaver
Journal:  Trends Cell Biol       Date:  2010-10-01       Impact factor: 20.808

Review 5.  Fibroblasts and the ground they walk on.

Authors:  Daniel J Tschumperlin
Journal:  Physiology (Bethesda)       Date:  2013-11

6.  MT1-MMP-dependent remodeling of cardiac extracellular matrix structure and function following myocardial infarction.

Authors:  Gerald C Koenig; R Grant Rowe; Sharlene M Day; Farideh Sabeh; Jeffrey J Atkinson; Kenneth R Cooke; Stephen J Weiss
Journal:  Am J Pathol       Date:  2012-03-29       Impact factor: 4.307

Review 7.  Matrix metalloproteinase collagenolysis in health and disease.

Authors:  Sabrina Amar; Lyndsay Smith; Gregg B Fields
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-04-26       Impact factor: 4.739

8.  Characterization and regulation of MT1-MMP cell surface-associated activity.

Authors:  Sonia Pahwa; Manishabrata Bhowmick; Sabrina Amar; Jian Cao; Alex Y Strongin; Rafael Fridman; Stephen J Weiss; Gregg B Fields
Journal:  Chem Biol Drug Des       Date:  2018-12-19       Impact factor: 2.817

9.  MT1-MMP controls human mesenchymal stem cell trafficking and differentiation.

Authors:  Changlian Lu; Xiao-Yan Li; Yuexian Hu; R Grant Rowe; Stephen J Weiss
Journal:  Blood       Date:  2009-11-09       Impact factor: 22.113

10.  Matrix metalloproteinase 9 is associated with peritoneal membrane solute transport and induces angiogenesis through β-catenin signaling.

Authors:  Manreet Padwal; Imad Siddique; Lili Wu; Katelynn Tang; Felix Boivin; Limin Liu; Jennifer Robertson; Darren Bridgewater; Judith West-Mays; Azim Gangji; Kenneth Scott Brimble; Peter J Margetts
Journal:  Nephrol Dial Transplant       Date:  2017-01-01       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.